Mehta, Priya, Vipulkumar Thummar, and Harsh Bhavsar. 2026. “Clinical Outcomes of Neoadjuvant Dual HER2 Blockade With pertuzumab/Sigrima and trastuzumab/Vivitra Biosimilars: Real-World Evidence in HER2-Positive Breast Cancer in India”. International Journal of Research in Medical Sciences 14 (4):1584-88. https://doi.org/10.18203/2320-6012.ijrms20260973.